TIRZ 35mg

Tirzepatide is a novel dual agonist that targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is currently being studied for its potential role in blood glucose regulation, weight management, and metabolic health research. Tirzepatide has attracted significant attention in scientific and clinical research settings for its ability to mimic incretin hormones that regulate appetite and insulin secretion.

⚠️ Disclaimer

• For Research Use Only. Not for human consumption, medical, veterinary, or household use.

• This compound is provided exclusively for in vitro laboratory research purposes.

• No clinical claims are made regarding safety, efficacy, or intended use.

• Handling should only be performed by qualified professionals with appropriate laboratory safety protocols in place.